3児の親さん薬剤師のブログ

とある薬剤師です。感染症治療を考える素材をちょこっと提供。noteもあります https://note.com/twin1980

Pathogens Causing Central-Line-Associated Bloodstream Infections in Acute-Care hospitals-United States, 2011-2017

ICHPに報告された、CDCデータから読み取ったCLBSIの原因菌について。

 

www.ncbi.nlm.nih.gov

 感想

 

興味深い報告。CLBSIの原因菌として真菌や腸内細菌の割合が増えてきた。

感染制御的な要因もありそうですが。

日本データも注視必要ですね。

 

 

 

Abstract


OBJECTIVE:

To describe pathogen distribution and rates for central-line-associated bloodstream infections (CLABSIs) from different acute-care locations during 2011-2017 to inform prevention efforts.

METHODS:

CLABSI data from the Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN) were analyzed. Percentages and pooled mean incidence density rates were calculated for a variety of pathogens and stratified by acute-care location groups (adult intensive care units [ICUs], pediatric ICUs [PICUs], adult wards, pediatric wards, and oncology wards).

RESULTS:

From 2011 to 2017, 136,264 CLABSIs were reported to the NHSN by adult and pediatric acute-care locations; adult ICUs and wards reported the most CLABSIs: 59,461 (44%) and 40,763 (30%), respectively. In 2017, the most common pathogens were Candida spp/yeast in adult ICUs (27%) and Enterobacteriaceae in adult wards, pediatric wards, oncology wards, and PICUs (23%-31%). Most pathogen-specific CLABSI rates decreased over time, excepting Candida spp/yeast in adult ICUs and Enterobacteriaceae in oncology wards, which increased, and Staphylococcus aureus rates in pediatric locations, which did not change.

CONCLUSIONS:

The pathogens associated with CLABSIs differ across acute-care location groups. Learning how pathogen-targeted prevention efforts could augment current prevention strategies, such as strategies aimed at preventing Candida spp/yeast and Enterobacteriaceae CLABSIs, might further reduce national rates.

 

 

ASM臨床微生物学プラチナレファランス

ASM臨床微生物学プラチナレファランス

  • 発売日: 2020/02/04
  • メディア: 単行本